Table 1.
Patient characteristics at the baseline.
| Variables | All patients (n = 329) | Survivors (n = 308) | Nonsurvivors (n = 21) | P |
|---|---|---|---|---|
| Gender (female/male) | 84/245 | 80/228 | 4/17 | 0.483 |
| Age (years) | 51 (44–60) | 51 (43–59) | 51 (46–67) | 0.088 |
| WBC (×109/L) | 4.19 (2.91–6.72) | 3.97 (2.82–6.50) | 6.78 (5.44–8.46) | <0.001 |
| Lymphocyte (×109/L) | 0.87 (0.54–1.44) | 0.86 (0.53–1.43) | 1.21 (0.62–1.67) | 0.489 |
| Monocyte (×109/L) | 0.34 (0.23–0.61) | 0.32 (0.22–0.55) | 0.77 (0.45–1.11) | <0.001 |
| Neutrophil (×109/L) | 2.66 (1.70–4.73) | 2.53 (1.67–4.38) | 5.34 (3.65–6.89) | <0.001 |
| Hemoglobin (g/L) | 101.55 ± 25.67 | 101.95 ± 25.59 | 95.71 ± 26.80 | 0.282 |
| PLT (×109/L) | 63.0 (41.0–101.5) | 60.5 (41.0–100.5) | 65.0 (37.5–105.0) | 0.523 |
| PMR | 184.62 (115.27–300.55) | 194.04 (127.27–311.61) | 82.43 (45.66–112.01) | <0.001 |
| Albumin (g/L) | 30.7 ± 6.2 | 31.0 ± 6.2 | 27.7 ± 5.3 | 0.020 |
| ALT (U/L) | 30.8 (19.2–63.7) | 29.0 (18.8–61.2) | 50.6 (26.5–107.6) | 0.475 |
| AST (U/L) | 45.3 (29.1–80.6) | 42.8 (28.8–78.4) | 77.8 (52.3–165.2) | 0.682 |
| Total bilirubin (μmol/L) | 28.2 (17.2–55.1) | 27.4 (16.7–49.7) | 231.6 (52.0–428.3) | <0.001 |
| Creatinine (μmol/L) | 64.7 (53.2–76.6) | 64.3 (52.7–75.3) | 80.9 (55.9–122.0) | 0.308 |
| MELD score | 9.69 (6.36–14.62) | 9.09 (6.09–13.28) | 21.10 (16.00–26.70) | <0.001 |
| INR | 1.38 (1.26–1.59) | 1.38 (1.25–1.58) | 1.81 (1.41–2.55) | <0.001 |
Data are expressed as number, mean ± standard deviation, or median (interquartile range).